A head-to-head clinical comparison of peptide therapy (BPC-157, TB-500, GHK-Cu) and CBD for athletic recovery, tissue repair, and inflammation. Covers safety, dosing, alcohol interactions, bruising, and cancer risk with primary source citations.
A direct clinical comparison of repair peptides (BPC-157, TB-500, GHK-Cu) versus corticosteroids for musculoskeletal recovery, wound healing, and inflammation control, including mechanisms, evidence, risks, and when each approach is appropriate.
A head-to-head clinical comparison of therapeutic peptides (BPC-157, TB-500, GHK-Cu) and platelet-rich plasma (PRP) for tissue repair, joint health, and performance recovery. Mechanisms, evidence, dosing, and how to choose.
Can you drink alcohol while using peptides like BPC-157, sermorelin, or CJC-1295? Learn the pharmacological conflicts, injection-site risks, cancer concerns, and exact timing windows your prescribing clinician wants you to follow.
A guide covering which peptides may help or harm autoimmune conditions, long-term safety data, cancer risk, alcohol interactions, and injection-site bruising, with primary-source citations throughout.
A clinically grounded guide to combining peptides with creatine for muscle growth, fat loss, recovery, and bone density. Covers athletes, postmenopausal women, older adults, and post-surgical patients.
A guide to combining GLP-1 receptor agonists with growth hormone-releasing peptides (sermorelin, ipamorelin, CJC-1295, tesamorelin, BPC-157) for athletes, postmenopausal women, and older adults. Covers dosing evidence, drug interactions, and who qualifies.
A deep dive into how TB-500 (Thymosin Beta-4) binds G-actin, promotes angiogenesis, and compares to BPC-157, copper peptides, corticosteroids, and PRP for tissue repair.
A breakdown of TB-500 (Thymosin Beta-4) side effects, injection reactions, cancer risk, and how they compare with BPC-157, GHK-Cu, and other research peptides.
A deep-dive into ARA 290 (cibinetide), a non-hematopoietic erythropoietin peptide fragment studied for neuropathic pain, inflammation, and metabolic repair. Includes trial data, dosing context, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
A guide covering US peptide legality, FDA status, compounding rules, drug testing, injection technique, oral bioavailability, and cycling protocols with primary-source citations.
A breakdown of BPC-157 fragments, their proposed mechanism of action, comparison with TB-500/Ac-SDKP, GHRP-2 vs GHRP-6, and how regenerative peptide stacks are assembled, along with what the evidence does and does not support.
Most peptides are destroyed in the gut before reaching the bloodstream. Learn which peptides can be taken orally, which require injection, and what the science says about absorption, legality, and safety.
A clinical deep-dive into dermorphin topical applications, argireline, Matrixyl, SNAP-8, and copper peptides beyond GHK-Cu. Evidence-based guidance on doses, mechanisms, and what to realistically expect.
A guide to hexarelin, covering its mechanism, clinical evidence, dosing protocols, safety data, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
A guide to humanin, covering its mechanism, reported benefits, dosing data from published trials, comparisons with epitalon, MOTS-c, SS-31, and FOXO4-DRI, and what the current FDA regulatory landscape means for patients.
IGF-1 LR3 and DES are unapproved research chemicals with no human trials. Learn how they differ from mecasermin, the only FDA-approved IGF-1 drug.
A guide to the LF-15 Camel peptide stack, covering thymosin alpha-1, thymulin, larazotide, and KPV systemic. Includes mechanisms, dosing protocols, clinical trial data, and regulatory status.
A guide to longevity peptide stacks, covering Epitalon, MOTS-C, SS-31, and Humanin: mechanisms, clinical evidence, dosing protocols, and safety considerations.
A clinical breakdown of Melanotan 1 (afamelanotide), its FDA-designated status, melanocortin receptor mechanism, real trial data, and how it compares to AOD 9604, HGH Frag 176-191, Melanotan 2, and experimental myostatin inhibitors.
A guide to melatonin and cosmetic peptides for skin aging, covering argireline, matrixyl, SNAP-8, GHK-Cu, and emerging copper peptide variants with real trial data and dosing context.
A guide to MGF mechano growth factor, its relationship to IGF-1 splice variants, IGF-1 LR3, IGF-1 Des, and IGFBP modulation, with full citations to primary research.
A guide to mitochondrial and longevity peptides including MOTS-c, Epitalon, SS-31, Humanin, and FOXO4-DRI. Covers mechanisms, clinical and preclinical evidence, dosing, safety, and regulatory status.
A guide to N-acetyl epitalon, covering its telomere biology, comparison with standard epitalon, regenerative peptide stacks including BPC-157 and TB-500 fragments, GHRP-2 vs GHRP-6 dosing, and current evidence gaps.
Separate N-Acetyl Semax claims from plain Semax research, including questions about acetylation, brain exposure, cognitive effects, and formulation stability.
A overview of the leading nootropic peptides, including Semax, Selank, Cerebrolysin, and Dihexa. Covers mechanisms, doses, trial data, safety profiles, and prescribing considerations.
A guide to P21 peptide covering its mechanism, comparison with Semax, Selank, Cerebrolysin, and Dihexa, the current evidence base, dosing concepts, and safety considerations.
Everything patients need to know about receiving peptides by air shipment: legality, storage on arrival, injection pain, drug testing, and oral bioavailability, with primary-source citations throughout.
A guide covering peptide half-life science, how long common therapeutic peptides stay active, injection site pain, oral absorption limits, drug-test detection, and US legal status. Includes real doses, named trials, and sourced statistics.
Learn exactly how temperature, light, pH, and oxidation degrade therapeutic peptides. Covers FDA 503A compounding rules, purity testing standards, sterility requirements, and step-by-step reconstitution storage protocols backed by primary clinical sources.
A guide to using peptides alongside GLP-1 medications like semaglutide. Covers legality, drug testing, injection technique, and oral delivery options with citations to primary clinical sources.
A clinical guide to combining peptides with testosterone replacement therapy (TRT), covering top stacks, mechanisms, dosing protocols, legal status in the US, drug testing, injection technique, and oral bioavailability.
A guide to using peptide therapy alongside prescription medications, covering drug interactions, legal status, drug testing, injection technique, and oral bioavailability.
A clinical breakdown of the regen peptide stack, covering BPC-157 fragments, TB-500 fragments, N-acetyl epitalon, and GHRP-2 vs GHRP-6 dosing, mechanisms, and evidence.
What has Selank actually been studied for? Review the small human anxiety study, its comparator, and the limits of claims about cognition, dependence, and long-term use.
Explore Semax research, including stroke rehabilitation, BDNF measurements, study limitations, and why those findings do not establish healthy-person cognitive benefits.
A guide to thymulin, thymosin alpha-1, larazotide, and KPV. Covers mechanisms, dosing, trials, stack protocols, and regulatory status.
A clinician-level review of how micronized progesterone (Prometrium) affects hair cycling, sebum production, and skin aging, with primary-literature citations and practical dosing guidance.
A physician-level review of every documented dermatologic effect of bremelanotide (PT-141), including flushing, hyperpigmentation, and what the RECONNECT trial data say about hair changes.
A guide to the safety profile of rapamycin (sirolimus) in adults aged 30 to 49, covering dose-dependent risks, monitoring protocols, drug interactions, and what the PEARL trial data actually show.
A guide to sirolimus dose adjustments in hepatic impairment, covering PK changes, FDA labeling, clinical monitoring, and emerging longevity-use data.
A citation-dense guide to sirolimus safety during pregnancy and breastfeeding, covering mechanism, teratogenicity data, transplant guidelines, and off-label longevity use.
A guide to sirolimus dosing adjustments, pharmacokinetics, and monitoring in patients with chronic kidney disease, transplant nephropathy, and off-label longevity use.
A clinician-level review of how rapamycin (sirolimus) affects appetite, hunger signaling, and food cravings, covering transplant doses, low-dose longevity protocols, mTOR biology, and the PEARL trial data.
An evidence-audited look at how rapamycin (sirolimus) affects bone remodeling, what transplant-dose data actually show, what is unverified, and how to think about monitoring if you are on the drug for transplant immunosuppression or off-label longevity use.
A physician-level review of the cancer risk data for rapamycin (sirolimus), covering transplant cohorts, mTOR biology, animal data, and what the PEARL trial tells us about off-label longevity use.
A deep dive into how rapamycin (sirolimus) affects cognition in humans and animals, covering mTOR biology, clinical trial data including PEARL (2024), dosing, and safety considerations for off-label longevity use.
A comparison of compounded sirolimus versus branded Rapamune, covering bioavailability, regulatory status, dosing for off-label longevity use, and what the PEARL trial data show.
A deep dive into how rapamycin (sirolimus) affects liver function, including hepatotoxicity risk, transaminase changes, lipid effects, and monitoring protocols backed by primary literature.
A clinician-level review of how rapamycin (sirolimus) affects mood, cognition, anxiety, and depression, covering mTOR neuroscience, PEARL trial data, and practical prescribing guidance.
A clinician-level review of rapamycin microdosing protocols for longevity, covering PEARL and other primary trials, dosing regimens, pharmacology, safety data, and what board-certified physicians consider before prescribing off-label sirolimus.
A clinical deep-dive into sirolimus pharmacokinetics, wound healing risks, mTOR-mediated metabolic effects, and dosing considerations specific to post-bariatric surgery patients.
A physician-level guide to safely restarting sirolimus after acute illness, covering hold durations, immune recovery markers, dose re-escalation protocols, and the latest evidence from PEARL (2024) and transplant guidelines.
A physician-level guide to the sirolimus pre-surgery hold window: how long to stop rapamycin before an operation, why wound healing and immune suppression demand a specific washout period, and how to restart safely after surgery.
A clinician-level guide to adjusting sirolimus dosing, lab monitoring, and infection precautions by season, with primary-literature citations and a practical seasonal framework.
A deep dive into how rapamycin (sirolimus) affects sexual function in men and women, covering mTOR biology, clinical trial data, dose-dependent effects, and practical management strategies.
A clinical deep-dive into how rapamycin (sirolimus) affects sleep architecture, circadian biology, mTOR signaling in the brain, and what the PEARL trial and related primary literature reveal for patients and prescribers.
A clinical deep-dive into alprostadil (Caverject, MUSE) FAERS adverse event reports, FDA labeling history, post-market surveillance findings, and what they mean for prescribers and patients.
A detailed regulatory breakdown of AOD-9604 (HGH fragment 176-191) compounding legal status, FDA classification, safety data, and what prescribers should do before ordering this peptide.
A complete regulatory timeline of tadalafil (Cialis): original FDA approval dates, indication expansions, label revisions, post-market safety signals, and what the current prescribing information requires.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.